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Özet
Prostat kanseri erkeklerde en sık gözlenen prostat malignensilerindendir ve duk-
tal adenokarsinom klinik ve histolojik özellikleri ile belirgin patolojik bir subtipi-
dir. Yetmiş altı yaşında Kronik lenfositik lösemi/Küçük hücreli lenfositik lenfoma-
lı (KLL/SLL) erkek hasta alt üriner sistem semptomları ile hastanemize başvurdu. 
Son prostat spesifik antijen seviyesi (PSA) 26 ng/ml ile bir çok transrektal ultraso-
und rehberliğindeki biopsiler uygulandı ve patoloji raporları benign prostat hiperp-
lazisi ve non-spesifik prostatit olarak sonuçlandı. Semptomların devam etmesi 
üzerine prostata transuretral rezeksiyon uygulandı. Materyalin patolojik değerlen-
dirilmesinde benign hiperplazik prostat dokuları arasında stroması olmayan ade-
nokarsinom odakları gözlendi. Tümör 4+4 Gleason patern skoru ile duktal adeno-
karsinom olarak tanı aldı. Metastaza bağlı lomber vertebrada kemik sintigrafisin-
de aktivite tutulumu vardı. Bilgisayarlı tomografide önceki KLL/SLL ‘ye bağlı ingu-
inal ve sağ iliak lenfadenopati izlendi. Total androjen kısıtlama tedavisi ve bilate-
ral orşiektomi uygulandı. 3 ay sonra biokimyasal ve radyolojik görüntüleme sonuç-
larına göre radyoterapi tedavisi planlandı. Duktal adenokarsinoma konvansiyonel 
adenokarsinomdan farklı klinik davranışı olan prostatın nadir  bir subtipidir. Diğer 
yandan KLL/SLL takibi yapılan bir hastada sekonder bir malignensi olarak ortaya 
çıkması olguyu değerli kılmaktadır.
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Abstract
Prostate cancer is the most common malignancy in men and ductal adenocar-
cinoma is a pathologic subtype with specific histological and clinical features. 
Seventy-six year-old male patient with chronic lymphocytic leukemia/small lym-
phocytic lymphoma (CLL/SLL) admitted to our hospital with lower urinary tract 
symptoms. The last prostate specific antigen (PSA) level was 26 ng/ml and serial 
transrectal ultrasound guided biopsies were administered and benign prostate 
hyperplasia and non-specific prostatitis were the results of pathology reports. Due 
to the persistence of the symptoms transurethral resection of the prostate was 
performed. In the pathologic evaluation of the material adenocarcinoma focuses 
without stroma has been observed between the hyperplasic prostate tissues. The 
tumor has been diagnosed as ductal adenocarcinoma with 4+4 Gleason pattern 
score. Bone scintigraphy was revealed activity uptake on lomber vertebral column 
due to metastasis. Computerized tomography was revealed previous bilateral in-
guinal and right iliac lymphadenopathy due to CLL/SLL. Total androgen depriva-
tion therapy and bilateral orchiectomy was applied. After three mounts according 
to biochemical and imaging results,  radiotherapy cure began. Ductal adenocar-
cinoma is a rare subtype of prostate carcinoma with clinical behavior from that 
seen in conventional adenocarcinoma. On the other hand it is worth to point out 
the occurence of this entity as second malignancy during follow-up of CLL/SLL.
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This case was presented as a poster in Avrasian Urooncology congress in 2015.
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Introduction
Ductal adenocarcinoma (DA) of the prostate is a rare histologic 
subtype of prostate cancer that was first defined by Melicow 
et al. as endometrial carcinoma of prostatic utricule in 1967 
[1]. Prostate spesific antigen levels (PSA) seem to be in normal 
levels and the behaviour of the tumor is uncertain [2]. 
DA usually presents with aciner adenocarcinoma and the pure 
form is rare constituting 0.4-0.8 % of all radical prostatectomy 
and biopsy specimens [3]. It may be misdiagnosed as various 
benign, precancerous and malign lesions like prostatic urethral 
polyps, high grade prostatic intraepithelial neoplasia (HG-PIN) 
and colorectal adenocarcinoma.
Postatic DA may originate either from large primary periure-
thral prostatic ducts or rarely from peripheral prostatic ducts 
[4].
We would like to describe our case which we diagnosed in 
transurethral resection specimen  incidentally as DA with mild 
PSA levels and prostatism symptoms in a chronic lymphocytic 
leukemia/small lymphocytic lymphoma (CLL/SLL) patient.
Case Report
Seventy-six year-old male patient with CLL/SLL admitted to 
Mustafa Kemal University hospital Urology department outpa-
tient clinic with lower urinary tract symptoms. Prostate gland 
was 90 gram in ultrasonography (US) examination. The last 
total PSA and free PSA level was 23.3 and 5.7 ng/ml, respec-
tively and three consecutive twelve core transrectal ultrasound 
guided biopsies were administered and benign prostate hyper-
plasia and non-specific prostatitis were the results of pathology 
reports. Due to the persistence of the symptoms transurethral 
resection of the prostate (TURP) was performed, during TURP 
procedure there was a papillary lesion protruded from right 
apex of the prostatic urethra and the material has been sent 
to pathology laboratory. In the microscopic evaluation of the 
specimen adenocarcinoma focuses without stroma has been 
observed between the hyperplasic prostate tissues (Figure 1). 
The nuclear morphology was different from classic acinar ade-
nocarcinoma. To confirm the diagnosis and differentiate it from 
metastatic tumors an immunohistochemical panel was applied. 
While CK7, CK20 were negative, PSA and AMACR were positive 
in immunohistochemical studies (Figure 2-3). The tumor has 
been diagnosed as ductal adenocarcinoma with 4+4 Gleason 
pattern score. Bone scintigraphy was revealed activity uptake 
on lomber vertebral column. Computerized tomography was re-
vealed previous bilateral inguinal and right iliac lymphadenopa-
thy due to CLL. Total androgen deprivation therapy and orchiec-
tomy was  applied, after three mounts according to biochemical 
and imaging results, radiotherapy cure was began.
Discussion
Prostatic DA is a rare variant most commonly growing as exo-
phytic mass lesions in the uretra. There are various mimickers 
of this entity that it should be recognised by pathologists and 
uropathologists in daily practice [4].
DAs are often localised at the central ducts of the gland. There-
fore they are usually seen in TURP and radical prostatectomy 
specimens and less diagnosed in needle biopsies. Our case had 
also two serial transrectal US guided biopsies but final proce-
dure with TURP demonstrated the tumor. Sfoungaristos et al. 
reported an 82 year old Caucasian man with  DA that was diag-
nosed in TURP specimen like our case [5].
DA is seen in elderly man with a range of 65 to 87 with obstruc-
tive symptoms and gross hematuria [6]. Our patient was 76 
years old at the time of diagnosis and admitted to our clinic 
with lower urinary tract symptoms.
DA cells express PSA but PSA levels are not always high in these 
tumors as in our patient (26 ng/ml) that could be in inflamma-
tion or  hyperplasias of the gland.
Figure 1-2. Adenoid and cribriform structures with atypical columnar epithelium 
without stroma between the benign prostate glands (Hematoxilen&Eosinx200).
Figure 3. AMACR positivity in tumor cells (AMACRX100).
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The cystourethroscopic appearence of DA is described as exo-
phytic and polypoid mass projecting into the uretra or near the 
verumontanum [6]. Kan et al. defined 10 of their cases  as in-
tra luminal growth masses during cystoscopy in their review of 
Hong Kong DA series [2]. We have observed an exophytic mass 
lesion projecting into the lumen at the prostate apex with right 
wall laterilization.
DA has benign and malign mimickers. Prostatic urethral polyp is 
a polipoid lesion lined by benign appearing prostatic glandular 
epithelium and it can be confused with DA in fragmentated nee-
dle biopsies. HG-PIN cribriform type is a difficult entitity that 
should be remembered in differential diagnosis. HG-PIN consti-
tutes with micropapillary cores while DA presents with true pap-
illary cores. Beside this DA is recognisable with distinct atypia 
and large, back to back glands and usually comedonecrosis.  DA 
might be confused with colorectal carcinoma metastasis. The 
verification of the diagnosis need immunohistochemical stud-
ies like PSA and PSAP. Another tumoral lesion that we should 
remember is papillary urothelial carcinoma in differential diag-
nosis; the cribriform architecture of DA is missing and nuclei 
of the tumor cells are more pleomorphic [4]. In the microscobic 
evaluation of the specimen we have found tumor composed of 
cribriform and adenoid structures with atypical columnar cells 
between the hyperplastic prostatic tissues. We have immunos-
tained the tumoral  tissue by Cytokeratin 7 and 20, AMACR, P63 
and PSA. While Cytokeratin 7, 20 were negative, AMACR and 
PSA were strong and diffuse positive confirming our diagnosis 
of prostatic DA. P63 was diminished in neoplastic ducts.
In the literature DA is defined as a more agressive neoplasm 
compared to aciner adenocarcinoma. DA is mostly graded as 
4+4= 8 whereas in cases of mixed ductal and aciner patterns 
ductal component should be assigned to Gleason patern 4 ac-
cording to Gleason histopathologic scoring system [2]. We have 
also reported our case as 4+4=8 with its morphologic architec-
ture and ductal differentiation.
Kan et al.  reported bone and rectum invasions in 7 of their 20 
DAs [2]. Our patient has lomber vertebra metastasis and alive 
receiving radiotherapy with no morbidity.
Engin et al. declared the incidence of multipl primary cancers 
as 0.83% among cancer patients [7]. CLL/SLL  patients are 
candidates for developing a second cancer and an increased 
frequency of certain cancer types twice times more compared 
to normal population because of  disease or therapy related im-
munsupression. Tsimberidau et al. reported  prostate carcinoma 
synchronous with CLL in 12.8 % of their series [8]. Our patient 
is also under follow-up  for CLL/SLL for three years and devel-
oped DA  after two years.
DA of the prostate has unique morphological, clinical features 
and agressive behaviour. It should be remembered in cases with 
non-specific pathologic  findings in periferic prostate biopsies 
of patients with persisant lower urinary tract symptoms.We 
should also point out this rare entity with its occurence during 
CLL/SLL follow-up.
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Figure 4. PSA positivity in tumor cells (PSAX100).
